Central nervous system neurotransmission modulation

Central nervous system (CNS) neurotransmission modulation is a broad physiological process involving the regulation of signal transmission between neurons via chemical messengers known as neurotransmitters (StatPearls, 2023). It is not a specific molecular target but rather a therapeutic objective achieved by interacting with various proteins such as G protein-coupled receptors, ion channels, and transporters (NCBI, 2022). This process is critical for maintaining homeostasis in the brain, and its dysregulation is linked to numerous conditions including epilepsy, depression, and neurodegenerative diseases like Alzheimer's (PubMed, 2021). Pharmacological agents modulate neurotransmission by altering the synthesis, release, reuptake, or receptor binding of chemicals like glutamate, GABA, dopamine, and serotonin (NIH, 2023). Because it encompasses a wide range of distinct biological pathways and diverse molecular entities, it is classified as a mechanism of action or therapeutic category rather than a single drug target. Effective modulation requires precise targeting of specific receptors or circuits to avoid widespread side effects like sedation or cognitive dysfunction. Therapeutic interventions in this area often aim to restore the balance between excitatory and inhibitory signaling within neural circuits to treat complex neurological and psychiatric symptoms.

Other names

CNS neurotransmission modulationSynaptic modulationNeuromodulationNeurotransmitter modulation

Modulation of neurotransmitter synthesis, release, reuptake, or receptor binding to alter neuronal signaling intensity and duration.